White paper

AI and Machine Learning in Intellectual Property

AI and Machine Learning in Intellectual Property

Maximal Challenges, Opportunities, and the Evolving Role of IP Professionals

 

Artificial intelligence and machine learning are reshaping the field of intellectual property. This white paper presents expert insights on patenting AI/ML inventions, integrating AI into IP workflows, and the changing role of IP professionals.

Edited by Jean-Claude Alexandre Ho LL.M., the white paper is based on interviews with leading IP experts and was summarized using NotebookLM.


We invite you to download the full white paper 'AI and Machine Learning in Intellectual Property' to explore the findings in detail.



 

Download

White paper

AI and Machine Learning in Intellectual Property

Download

Free Download

Once you have completed the following fields, you can download the desired content. Alternatively, log in to your customer portal. The document will then be freely available to you.
I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.
3 + 1 =   

Events for „IP“

Do filter
Sort
Tiles
Lists
Qualification Course Regulatory Affairs Manager

With our modular qualification course, you can expand your competencies in drug regulatory affairs in a targeted and practice-oriented manner. You design your learning pathway individually and set professional focus areas in line with your occupational requirements. Including an overall certificate and up to 30% price advantage compared with individual bookings.

online 01/01 - 31/12/2026
e-Learning: GDP - Basic Training

This e-Learning programme will provide you with knowledge on Good Distribution Practice in today's pharmaceutical industry

online
e-Learning: AMNOG briefly and concisely

e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation

online
e-Learning: Refresher Medical Device Advisor §83 MPDG

Our e-learning, specially tailored for medical device advisors, provides you with the essential knowledge to navigate your professional duties confidently and in full legal compliance.

online
e-Learning: Medical Device Advisor §83 MPDG

Our e-learning, specially tailored for medical device advisors, provides you with the essential knowledge to navigate your professional duties confidently and in full legal compliance.

online
e-Learning: Introduction to EU Marketing Authorisation

This e-learning programme will familiarise you with the regulatory affairs principles involved in applying for a marketing authorisation in Europe (MRP, DCP, CP) . It will also introduce you to post-authorisation duties (renewal, variation...).

online
e-Learning: EU Variation System and Procedures

This e-Learning programme will provide you with detailed knowledge on the classification, grouping and submission of variations in the EU.

online
e-Learning: Common Technical Document and eCTD

Do you need know how regarding CTD/eCTD & CMC? Then this e-learning programme is the fast track to becoming knowledgeable in this field. No prior dossier experience is required.

online
Regulatory Affairs Starter Pack

Three e-Learning programmes in one bundle: Get a solid foundation in EU marketing authorisation procedures, the EU variation system and the Common Technical Document (eCTD). Your fast track into EU Regulatory Affairs - at a special bundle price.

online 01/01 - 31/12/2026
Generative AI Workshop for Patent Practitioners

Join our one-day course and discover how to revolutionize your patent work with the power of generative AI. This immersive workshop offers patent attorneys, counsels, and engineers a unique opportunity to gain hands-on experience with generative AI.

online 15/04/2026
online 14/10/2026
Marketing Authorisation Procedures in the EU

- Registration open until 21 April 2026. Remaining places subject to availability. - This seminar provides an in-depth exploration of EU drug marketing authorisation, focusing on regulatory frameworks, application types and procedures. It covers mutual recognition, decentralised and centralised procedures (MRP, DCP, CP) in detail, providing essential insights for successful EU drug approval.

online 22/04/2026